|4Feb 18, 7:31 PM ET

Elazzouzi Amy 4

4 · Aura Biosciences, Inc. · Filed Feb 18, 2025

Insider Transaction Report

Form 4
Period: 2025-02-18
Elazzouzi Amy
Senior Vice President, Finance
Transactions
  • Sale

    Common Stock

    2025-02-18$7.75/sh1,404$10,88182,278 total
Footnotes (1)
  • [F1]The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4